Genstar Capital Acquires Advarra from Linden Capital Partners
June 6, 2019
Genstar Capital has signed and completed a definitive agreement to acquire Advarra, a leading provider of IRB, IBC and research compliance services, from Linden Capital Partners; Linden intends to reinvest as a minority investor upon closing. Advarra, headquartered in Columbia, Maryland, serves pharma, biotech, medical device companies, CROs and academic medical centers (relationships with over 3,200 institutional sites); Genstar plans to expand Advarra’s capabilities and pursue organic growth and strategic acquisitions.
- Buyers
- Genstar Capital
- Targets
- Advarra
- Sellers
- Linden Capital Partners
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Blackstone and CPP Investments Acquire Majority Stake in Advarra
June 10, 2022
Healthcare Services
Private equity funds managed by Blackstone and Canada Pension Plan Investment Board (CPP Investments) signed a definitive agreement to make a majority investment in Advarra, a provider of regulatory, compliance and clinical trial technology solutions. Existing shareholders Genstar Capital and Linden Capital Partners — along with management — will remain significant investors as the new partners support Advarra’s next growth phase and invest in new services, data, and software capabilities.
-
Advarra Acquires Watermark Research Partners
July 20, 2021
Healthcare Services
Advarra has acquired Watermark Research Partners, a specialist provider of independent data safety monitoring board (DSMB), data monitoring committee (DMC) and endpoint adjudication committee (EAC) services. The deal adds biostatistics, protocol endpoint design, and data safety monitoring capabilities to Advarra's integrated IRB/IBC and research oversight offerings and expands its global research oversight footprint.
-
Advarra Acquires IntegReview IRB
November 9, 2020
Healthcare Services
Advarra has acquired IntegReview IRB, an AAHRPP-accredited central IRB based in Austin, Texas. The acquisition expands Advarra's IRB and early-phase clinical research capabilities, establishes its first office in the southern U.S., and will be integrated into Advarra over approximately six months.
-
Advarra Acquires IRB Company, Inc. (IRBco)
April 20, 2020
Healthcare Services
Advarra, a leading provider of IRB, IBC, research technology and compliance services, has acquired IRB Company, Inc. (IRBco), an AAHRPP-accredited central IRB that has conducted research reviews in the U.S. since 1981. The acquisition expands Advarra’s integrated IRB capabilities and institutional reach across the clinical research ecosystem.
-
Advarra Acquires Forte
September 5, 2019
Software
Advarra, a leading provider of IRB and research compliance services, announced its intent to acquire Forte, a market-leading provider of clinical research technology including the OnCore CTMS. The deal (Forte sold by Primus Capital) expands Advarra's site-centric technology and eClinical capabilities to better serve academic medical centers, cancer centers, and health systems.
-
Advarra Acquires Quorum Review IRB and Kinetiq Research and Technology Consulting
March 5, 2019
Healthcare Services
Advarra acquired Quorum Review IRB and its research and technology consulting division, Kinetiq, expanding the combined company's IRB, IBC and research compliance capabilities. The deal creates the largest global integrated IRB and research compliance services organization, broadening Advarra’s geographic reach (including Quorum’s Seattle office) and service offerings for pharmaceutical, biotech, device, academic and health system clients.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.